Filing excerpt
On November 19, 2025, Abbott entered into a definitive agreement to acquire Exact Sciences Corporation (Exact Sciences), which is expected to enable Abbott to enter the cancer diagnostics market.
The company plans to fund its acquisition of Exact Sciences with approximately $20 billion in new borrowings, significantly increasing its total indebtedness. This massive financial transaction will create pressure to find operational efficiencies and synergies, likely triggering large-scale system and process integration projects.
Filing excerpt
On November 19, 2025, Abbott entered into a definitive agreement to acquire Exact Sciences Corporation (Exact Sciences), which is expected to enable Abbott to enter the cancer diagnostics market.
What this signalsFilings often name leadership changes, deals and spending plans.
sec-10krestructuringGet every 10-K signal for Abbott and the companies you sell to, in the tools you already use.
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Abbott this week?”
The Signal API returns 10-K signals for any list of companies as JSON, for your CRM, warehouse or app.
Sign up and spend your free credits on the companies you sell to.
This page shows a preview. The full sec-10k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the APISignal
signal_nameValue in the APIassociationValue in the APIGET /v1/signals/62474d16-daf4-4030-a309-c75108d6cad6 returns this record as JSON. POST /v1/companies/enrich returns every signal for abbott.com.
{
"signal_id": "62474d16-daf4-4030-a309-c75108d6cad6",
"signal_type": "sec-10k",
"signal_subtype": "restructuring",
"detected_at": "2026-02-24T09:18:11.335+00:00",
"company": {
"name": "Abbott",
"domain": "abbott.com"
},
"data": {
"detail": "The company plans to fund its acquisition of Exact Sciences with approximately $20 billion in new borrowings, significantly increasing its total indebtedness. This massive financial transaction will create pressure to find operational efficiencies and synergies, likely triggering large-scale system and process integration projects.",
"metrics": {
"timeframe": "next_year",
"dollar_context": "Borrowings to fund the Exact Sciences acquisition",
"dollar_millions": 20000
},
"summary": "Abbott to incur $20B in new debt to fund acquisition of Exact Sciences Corporation",
"excerpts": "On November 19, 2025, Abbott entered into a definitive agreement to acquire Exact Sciences Corporation (Exact Sciences), which is expected to enable Abbott to enter the cancer diagnostics market.",
"relevance": 0.9,
"sentiment": "neutral",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/1800/000162828026010185/abt-20251231.htm",
"filing_date": "2026-02-20",
"filing_year": 2026,
"fiscal_year_end": "12/31",
"sales_relevance": "Change management needs",
"signal_category": "workforce"
}
}
curl https://signals.autobound.ai/v1/signals/62474d16-daf4-4030-a309-c75108d6cad6 \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"abbott.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.